局部复发鼻咽癌调强再放疗国际推荐
该国际推荐针对局部复发鼻咽癌的调强再放疗,通过广泛文献复习与国际专家小组多轮投票和迭代修订形成共识。推荐涵盖患者选择、靶区勾画、处方剂量和危及器官约束等再放疗细节,多数条款获得高至中度一致性。最终临床决策仍需结合患者个体情况权衡风险与获益。
要点
- 局部复发鼻咽癌再放疗需在 salvage 与正常组织毒性之间精细平衡。
- 推荐基于文献复习与多轮国际专家投票形成的共识,非高级别证据。
- 共识涵盖患者选择、靶区勾画、处方剂量和约束等再放疗细节。
核心结论
- 该文通过文献复习与共识构建,为复发鼻咽癌的根治性挽救治疗策略和再放疗优化提供参考。
- 最终临床决策须由主治医生全面考虑患者个体情况、风险获益平衡并接受并发症风险。
研究设计与样本
- 基于广泛文献复习的实用共识指南,由国际专家小组对争议领域多轮投票和迭代修订形成。
- 现有再放疗证据多为小样本回顾性研究,缺乏高级别证据。
主要发现
- 首轮问题显示即使专家间临床实践也存在差异,反映高质量支持数据缺乏和临床决策困难。
- 经意见交换和迭代修订,就一般治疗策略和再放疗细节形成高至中度一致性的推荐。
关键数值与推荐
- 推荐涉及患者选择、靶区勾画、处方剂量和约束等再放疗细节。
临床怎么用
- 可将该共识推荐作为局部复发鼻咽癌调强再放疗决策的参考框架。
- 应用时需结合患者个体情况,理解风险获益的精细平衡并接受并发症风险。
局限性
- 现有报告多为小样本回顾性研究,缺乏高级别证据。
- 推荐基于专家共识和多数投票,首轮投票已显示专家间实践存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Reirradiation for locally recurrent nasopharyngeal carcinoma (NPC) is challenging because prior radiation dose delivered in the first course is often close to the tolerance limit of surrounding normal structures. A delicate balance between achieving local salvage and minimizing treatment toxicities is needed. However, high-level evidence is lacking because available reports are mostly retrospective studies on small series of patients. Pragmatic consensus guidelines, based on an extensive literature search and the pooling of opinions by leading specialists, will provide a useful reference to assist decision-making for these difficult decisions. METHODS AND MATERIALS: A thorough review of available literature on recurrent NPC was conducted. A set of questions and preliminary draft guideline was circulated to a panel of international specialists with extensive experience in this field for voting on controversial areas and comments. A refined second proposal, based on a summary of the initial voting and different opinions expressed, was recirculated to the whole panel for review and reconsideration. The current guideline was based on majority voting after repeated iteration for final agreement. RESULTS: The initial round of questions showed variations in clinical practice even among the specialists, reflecting the lack of high-quality supporting data and the difficulties in formulating clinical decisions. Through exchange of comments and iterative revisions, recommendations with high-to-moderate agreement were formulated on general treatment strategies and details of reirradiation (including patient selection, targets contouring, dose prescription, and constraints). CONCLUSION: This paper provides useful reference on radical salvage treatment strategies for recurrent NPC and optimization of reirradiation through review of published evidence and consensus building. However, the final decision by the attending clinician must include full consideration of an individual patient's condition, understanding of the delicate balance between risk and benefits, and acceptance of risk of complications.
引用
- Ng WT, Soong YL, Ahn YC, et al. International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2021. PMID: 33571626. doi:10.1016/j.ijrobp.2021.01.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。